You just read:

MabVax Therapeutics' Fully Human Antibody Approach to Cancer Therapeutics and Imaging Featured in Three Presentations at AACR Annual Meeting in New Orleans

News provided by

MabVax Therapeutics Holdings, Inc.

18 Apr, 2016, 08:00 ET